Title |
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
|
---|---|
Published in |
Acta Neuropathologica Communications, January 2014
|
DOI | 10.1186/2051-5960-2-9 |
Pubmed ID | |
Authors |
Timothy A Couttas, Nupur Kain, Benjamin Daniels, Xin Ying Lim, Claire Shepherd, Jillian Kril, Russell Pickford, Hongyun Li, Brett Garner, Anthony S Don |
Abstract |
The greatest genetic risk factor for late-onset Alzheimer's disease (AD) is the ϵ4 allele of Apolipoprotein E (ApoE). ApoE regulates secretion of the potent neuroprotective signaling lipid Sphingosine 1-phosphate (S1P). S1P is derived by phosphorylation of sphingosine, catalysed by sphingosine kinases 1 and 2 (SphK1 and 2), and SphK1 positively regulates glutamate secretion and synaptic strength in hippocampal neurons. S1P and its receptor family have been subject to intense pharmacological interest in recent years, following approval of the immunomodulatory drug Fingolimod, an S1P mimetic, for relapsing multiple sclerosis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
United Kingdom | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Poland | 1 | <1% |
Australia | 1 | <1% |
Unknown | 156 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 30 | 19% |
Student > Ph. D. Student | 27 | 17% |
Student > Bachelor | 17 | 11% |
Student > Master | 12 | 8% |
Student > Doctoral Student | 8 | 5% |
Other | 24 | 15% |
Unknown | 41 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 30 | 19% |
Biochemistry, Genetics and Molecular Biology | 20 | 13% |
Neuroscience | 16 | 10% |
Medicine and Dentistry | 11 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
Other | 22 | 14% |
Unknown | 50 | 31% |